CAVALLONE, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 470
EU - Europa 123
AS - Asia 90
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 686
Nazione #
US - Stati Uniti d'America 454
SE - Svezia 56
CN - Cina 52
IT - Italia 30
BG - Bulgaria 22
CA - Canada 16
SG - Singapore 15
VN - Vietnam 12
RU - Federazione Russa 5
FI - Finlandia 3
JP - Giappone 3
DE - Germania 2
GB - Regno Unito 2
HK - Hong Kong 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
IN - India 1
IR - Iran 1
NL - Olanda 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
Totale 686
Città #
Fairfield 104
Woodbridge 49
Ashburn 39
Houston 29
Seattle 28
Wilmington 27
Beijing 23
Cambridge 23
Chandler 22
Sofia 22
Ann Arbor 20
New York 18
Ottawa 14
Des Moines 13
Princeton 11
Lawrence 10
Florence 8
Medford 8
Pisa 8
Xian 8
Boulder 6
Milan 4
Guangzhou 3
Nanjing 3
Rome 3
Changsha 2
Dearborn 2
Dong Ket 2
Hong Kong 2
Nanchang 2
Ogden 2
San Francisco 2
Sapporo 2
Shenyang 2
Abidjan 1
Auckland 1
Chiswick 1
Dallas 1
Groningen 1
Hangzhou 1
Hebei 1
Indiana 1
Jiaxing 1
Kilburn 1
Lappeenranta 1
Los Angeles 1
Monsummano Terme 1
Montreal 1
Naples 1
Nuremberg 1
Prague 1
Pune 1
Redwood City 1
Riyadh 1
Singapore 1
Taipei 1
Tianjin 1
Toronto 1
Vienna 1
Washington 1
Yinchuan 1
Totale 548
Nome #
Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease 89
Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection. 82
Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers 79
Circulating hepatitis B surface antigen particles carry hepatocellular microRNAs 72
TLR7 Agonist Increases Responses Of HBV-Specific T Cells And Natural Killer Cells In Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues. 64
null 59
null 57
HBV Pre-Core mutant in genotype-D infected children is selected during HBeAg/anti-HBe seroconversion and leads to HBeAg negative chronic hepatitis B in adulthood. 57
null 55
MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE METHODS TO IDENTIFY CLINICAL FEATURES PREDICTIVE OF PROGRESSIVE MAFLD 36
Optimization of in vitro HBV replication and HBsAg production in HuH7 cell line 24
Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy 13
Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient. 11
Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B 9
Highly dynamic changes of regional HBV epidemiology over two decades. 3
The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection 3
Totale 713
Categoria #
all - tutte 2.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201975 0 0 0 0 0 0 0 0 0 0 46 29
2019/2020199 32 9 6 13 21 25 19 19 19 10 25 1
2020/202168 7 1 5 2 1 0 1 5 6 7 20 13
2021/2022109 1 2 4 7 23 13 4 3 11 2 5 34
2022/2023110 18 14 9 2 13 17 2 9 11 0 11 4
2023/202474 5 5 9 0 3 25 17 1 3 1 5 0
Totale 713